Lorenzo Messa
Padova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
A small molecule targeting the interaction between human papillomavirus E7 oncoprotein and cellular phosphatase PTPN14 exerts antitumoral activity in cervical cancer cells.
Journal: Cancer letters
Published: April 27, 2023
HPV-induced cancers: preclinical therapeutic advancements.
Journal: Expert opinion on investigational drugs
Published: December 20, 2021
Targeted Disruption of E6/p53 Binding Exerts Broad Activity and Synergism with Paclitaxel and Topotecan against HPV-Transformed Cancer Cells.
Journal: Cancers
Published: November 19, 2021
A novel small-molecule inhibitor of the human papillomavirus E6-p53 interaction that reactivates p53 function and blocks cancer cells growth.
Journal: Cancer letters
Published: August 07, 2019
The isoquinoline alkaloid berberine inhibits human cytomegalovirus replication by interfering with the viral Immediate Early-2 (IE2) protein transactivating activity.
Journal: Antiviral research
Published: October 04, 2018
A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells.
Journal: Scientific reports
Published: January 10, 2018
HPV16 E6 and E7 upregulate the histone lysine demethylase KDM2B through the c-MYC/miR-146a-5p axys.
Journal: Oncogene
Published: April 27, 2017
4th European Seminars in Virology on Oncogenic and Oncolytic Viruses, in Bertinoro (Bologna), Italy.
4th European Seminars in Virology on Oncogenic and Oncolytic Viruses, in Bertinoro (Bologna), Italy.
Journal: Journal of cellular physiology
Published: September 21, 2016
Development and validation of a simple and robust HPLC method with UV detection for quantification of the hepatitis C virus inhibitor daclatasvir in human plasma.
Journal: Journal of pharmaceutical and biomedical analysis
Published: September 07, 2016
Daclatasvir plasma level and resistance selection in HIV patients with hepatitis C virus cirrhosis treated with daclatasvir, sofosbuvir, and ribavirin.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: May 16, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026